Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$100.79
2.222.25%
At close: Apr 30, 5:00 PM EST
$101.70
0.910.90%
After Hours: 6:24 PM EST
TransMedics Group Inc Analyst Ratings
TMDXNASDAQ
Earnings: Q1 2026 Earnings in 5 days from now on Tue May 5th, after the market close
TransMedics Group Analyst Ratings and Price Targets | NASDAQ:TMDX | Benzinga
TransMedics Group Inc has a consensus price target of $135.07 based on the ratings of 16 analysts. The high is $178 issued by Stephens & Co. on August 2, 2024. The low is $70 issued by JP Morgan on November 7, 2023. The 3 most-recent analyst ratings were released by Evercore ISI Group, Stifel, and JP Morgan on April 6, 2026, March 9, 2026, and February 25, 2026, respectively. With an average price target of $132.33 between Evercore ISI Group, Stifel, and JP Morgan, there's an implied 30.12% upside for TransMedics Group Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Evercore ISI Group
Stifel
JP Morgan
Oppenheimer
Piper Sandler
1calculated from analyst ratings
Analyst Ratings for TransMedics Group
Loading calendar...
FAQ
What is the target price for TransMedics Group (TMDX) stock?
The latest price target for TransMedics Group (NASDAQ:TMDX) was reported by Evercore ISI Group on April 6, 2026. The analyst firm set a price target for $118.00 expecting TMDX to rise to within 12 months (a possible 16.03% upside). 26 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for TransMedics Group (TMDX)?
The latest analyst rating for TransMedics Group (NASDAQ:TMDX) was provided by Evercore ISI Group, and TransMedics Group maintained their outperform rating.
When was the last upgrade for TransMedics Group (TMDX)?
The last upgrade for TransMedics Group Inc happened on October 23, 2025 when Needham raised their price target to $148. Needham previously had a hold for TransMedics Group Inc.
When was the last downgrade for TransMedics Group (TMDX)?
The last downgrade for TransMedics Group Inc happened on December 17, 2024 when JP Morgan changed their price target from $116 to $75 for TransMedics Group Inc.
When is the next analyst rating going to be posted or updated for TransMedics Group (TMDX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of TransMedics Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for TransMedics Group was filed on April 6, 2026 so you should expect the next rating to be made available sometime around April 6, 2027.
Is the Analyst Rating TransMedics Group (TMDX) correct?
While ratings are subjective and will change, the latest TransMedics Group (TMDX) rating was a maintained with a price target of $170.00 to $118.00. The current price TransMedics Group (TMDX) is trading at is $101.70, which is out of the analyst’s predicted range.
